Back to User profile » Dr Nobutaka Shimizu
Paper published by Dr Nobutaka Shimizu:
Original Research
Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume
Kuno T, Tamura K, Shimizu N, Fukuhara H, Fukata S, Ashida S, Karashima T, Satake H, Sawada K, Yamasaki I, Komatsu F, Kuroiwa H, Saito M, Inoue K
Research and Reports in Urology 2023, 15:157-164
Published Date: 22 May 2023